Impaza

General characteristics. Structure:

Active ingredient: antibodies to endothelial NO synthase affinely cleared – 0, 003 г*.
Excipients: lactose, cellulose microcrystallic, magnesium stearate.
Description:
Tablets of a ploskotsilindrichesky form with risky and a facet, from white till almost white color. On the flat party from risky MATERIA MEDICA text is put, on other flat party IMPAZA text is put.

Pharmacological properties:

Increases activity of endothelial NO synthase, recovers development by an endothelium of nitrogen oxide (NO) at sexual stimulation, increases contents in unstriated muscles cyclic guanine riboside-monophosphate (tsGMF) and promotes their relaxation that leads to increase in a krovenapolneniye of cavernous bodies and provides an erection, sufficient on force and duration.
Drug raises a libido (sexual desire) and satisfaction with sexual intercourse.
Regular use of drug promotes increase in content of testosterone in serum (at moderately reduced initial level).

Indications to use:

Disturbances of an erection (erectile dysfunction) of various origin.
Vegetative frustration of a climacteric at men (weakness, fatigue, decrease in physical activity, decrease in a libido, etc.).

Route of administration and doses:

On one reception - 1 tablet (to hold in a mouth before full dissolution - not during meal).

Regular reception. For stabilization of a sexual potentiality (ability to sexual intercourse) the treatment-and-prophylactic course lasting not less than 12 weeks is recommended. Depending on expressiveness of erectile dysfunction the frequency of reception can vary: from 1 tablet every other day to two receptions on a tablet daily, it is desirable in the evening.
If necessary course therapy can be repeated in 3-6 months.
Periodic reception. For incidental stimulation of an erection drug is accepted before sexual intercourse on 2 tablets in 1-2 hours prior to estimated proximity.

Features of use:

Lactose in this connection patients are not recommended to appoint it with an inborn galactosemia, a sprue of glucose or a galactose, or with an inborn lactose intolerance is a part of drug.

Side effects:

When using drug according to the specified indications and in the specified dosages of side effect it is not revealed.
Reactions of the increased individual sensitivity to drug components are possible.

Interaction with other medicines:

Impaza's use against the background of reception of nitrates for patients with coronary heart disease (an angina of exertion of the I-II functional class), and also use together with beta adrenoblockers, diuretics, inhibitors of the angiotensin-converting enzyme (ACE), antagonists of calcium is possible.

Contraindications:

The increased individual sensitivity to drug components.

Overdose:

At accidental overdose the dispepsichesky phenomena caused by the fillers which are a part of a dosage form are possible.

Storage conditions:

In the dry, protected from light place, at a temperature not above 25ºС. To store in the place, unavailable to children. Period of validity 3 years.

Issue conditions:

Without recipe

Packaging:

Tablets for a rassasyvaniye. On 20 tablets in a blister strip packaging from a film of polyvinyl chloride and aluminum foil.
Each blister strip packaging together with the instruction on a medical use is placed in a cardboard pack.